Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2893412rdf:typepubmed:Citationlld:pubmed
pubmed-article:2893412lifeskim:mentionsumls-concept:C0006462lld:lifeskim
pubmed-article:2893412lifeskim:mentionsumls-concept:C0040616lld:lifeskim
pubmed-article:2893412lifeskim:mentionsumls-concept:C0050079lld:lifeskim
pubmed-article:2893412lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2893412lifeskim:mentionsumls-concept:C1996904lld:lifeskim
pubmed-article:2893412lifeskim:mentionsumls-concept:C0204695lld:lifeskim
pubmed-article:2893412lifeskim:mentionsumls-concept:C1880497lld:lifeskim
pubmed-article:2893412lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:2893412lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:2893412lifeskim:mentionsumls-concept:C0066624lld:lifeskim
pubmed-article:2893412lifeskim:mentionsumls-concept:C0123905lld:lifeskim
pubmed-article:2893412lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:2893412pubmed:issue3lld:pubmed
pubmed-article:2893412pubmed:dateCreated1988-3-3lld:pubmed
pubmed-article:2893412pubmed:abstractTextThe effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), were examined. Gepirone dose-dependently increased feeding 2 and 4 h after injection, the magnitude of the response being larger than previously observed with any other 5-HT1A receptor ligand. Previous studies have suggested that buspirone and ipsapirone can block some of the behavioural effects of 8-OH-DPAT. However, gepirone, buspirone and ipsapirone did not inhibit feeding induced by 8-OH-DPAT. These results indicate that gepirone is a very efficacious appetite stimulant in rats and suggest that gepirone, buspirone and ipsapirone act as 5-HT autoreceptor agonists in the feeding model.lld:pubmed
pubmed-article:2893412pubmed:languageenglld:pubmed
pubmed-article:2893412pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893412pubmed:citationSubsetIMlld:pubmed
pubmed-article:2893412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2893412pubmed:statusMEDLINElld:pubmed
pubmed-article:2893412pubmed:issn0033-3158lld:pubmed
pubmed-article:2893412pubmed:authorpubmed-author:GilbertFFlld:pubmed
pubmed-article:2893412pubmed:authorpubmed-author:DourishC TCTlld:pubmed
pubmed-article:2893412pubmed:issnTypePrintlld:pubmed
pubmed-article:2893412pubmed:volume93lld:pubmed
pubmed-article:2893412pubmed:ownerNLMlld:pubmed
pubmed-article:2893412pubmed:authorsCompleteYlld:pubmed
pubmed-article:2893412pubmed:pagination349-52lld:pubmed
pubmed-article:2893412pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:meshHeadingpubmed-meshheading:2893412-...lld:pubmed
pubmed-article:2893412pubmed:year1987lld:pubmed
pubmed-article:2893412pubmed:articleTitleEffects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.lld:pubmed
pubmed-article:2893412pubmed:affiliationMerck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, UK.lld:pubmed
pubmed-article:2893412pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2893412pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2893412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2893412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2893412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2893412lld:pubmed